These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34773302)

  • 21. Photodynamic therapy for actinic keratosis of the forehead and scalp: a randomized, controlled, phase II clinical study evaluating the noninferiority of a new protocol involving irradiation with a light-emitting, fabric-based device (the Flexitheralight protocol) compared with the conventional protocol involving irradiation with the Aktilite CL 128 lamp.
    Vicentini C; Vignion-Dewalle AS; Thecua E; Lecomte F; Maire C; Deleporte P; Béhal H; Kerob D; Duhamel A; Mordon S; Mortier L
    Br J Dermatol; 2019 Apr; 180(4):765-773. PubMed ID: 30367470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis.
    Dirschka T; Ekanayake-Bohlig S; Dominicus R; Aschoff R; Herrera-Ceballos E; Botella-Estrada R; Hunfeld A; Kremser M; Schmitz B; Lübbert H; Puig S
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):288-297. PubMed ID: 30022544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of daylight photodynamic therapy after tailored pretreatment with ablative fractional laser or microdermabrasion: a randomized, side-by-side, single-blind trial in patients with actinic keratosis and large-area field cancerization.
    Wenande E; Phothong W; Bay C; Karmisholt KE; Haedersdal M; Togsverd-Bo K
    Br J Dermatol; 2019 Apr; 180(4):756-764. PubMed ID: 30117140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial.
    O'Gorman SM; Clowry J; Manley M; McCavana J; Gray L; Kavanagh A; Lally A; Collins P
    JAMA Dermatol; 2016 Jun; 152(6):638-44. PubMed ID: 26843523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
    Moloney FJ; Collins P
    Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized split-face clinical trial of conventional vs indoor-daylight photodynamic therapy for the treatment of multiple actinic keratosis of the face and scalp and photoaging.
    Arisi M; Rossi MT; Spiazzi L; Guasco Pisani E; Venturuzzo A; Rovati C; Tomasi C; Venturini M; Calzavara-Pinton PG
    J Dermatolog Treat; 2022 Jun; 33(4):2250-2256. PubMed ID: 34152936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of photodynamic therapy with amino-5-laevulinate nanoemulsion versus methyl-5-aminolaevulinate for actinic keratosis: A meta-analysis.
    Fu C; Kuang BH; Qin L; Zeng XY; Wang BC
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():408-414. PubMed ID: 31310826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Hahn S; Pabst G; Voss D; Foguet M; Schmitz B; Lübbert H; Szeimies RM; ;
    Br J Dermatol; 2013 Apr; 168(4):825-36. PubMed ID: 23252768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of occlusive vs non-occlusive application of 5-aminolevulinic acid (BF-200 ALA) on the efficacy and tolerability of photodynamic therapy for actinic keratosis on the scalp and face: A prospective within-patient comparison trial.
    Meierhofer C; Silic K; Urban MV; Tanew A; Radakovic S
    Photodermatol Photoimmunol Photomed; 2021 Jan; 37(1):56-62. PubMed ID: 32974974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment with 5-Fluorouracil Cream Enhances the Efficacy of Daylight-mediated Photodynamic Therapy for Actinic Keratosis.
    Nissen CV; Heerfordt IM; Wiegell SR; Mikkelsen CS; Wulf HC
    Acta Derm Venereol; 2017 May; 97(5):617-621. PubMed ID: 28093604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conventional versus daylight photodynamic therapy for actinic keratosis: A randomized and prospective study in China.
    Zhu L; Wang P; Zhang G; Zhang L; Liu X; Hu C; Yang X; Sroka R; Zhou Z; Wang X
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():366-371. PubMed ID: 30336290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients - a randomized controlled trial.
    Togsverd-Bo K; Lei U; Erlendsson AM; Taudorf EH; Philipsen PA; Wulf HC; Skov L; Hædersdal M
    Br J Dermatol; 2015 Feb; 172(2):467-74. PubMed ID: 24975199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daylight Photodynamic Therapy for Actinic Keratoses.
    Morton CA; Braathen LR
    Am J Clin Dermatol; 2018 Oct; 19(5):647-656. PubMed ID: 29752702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of photodynamic therapy on skin homeostasis in patients with actinic keratosis: A prospective observational study.
    Soto-Moreno A; Montero-Vilchez T; Diaz-Calvillo P; Molina-Leyva A; Arias-Santiago S
    Skin Res Technol; 2023 Dec; 29(12):e13493. PubMed ID: 38017667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential treatment with calcitriol and methyl aminolevulinate-daylight photodynamic therapy for patients with multiple actinic keratoses of the upper extremities.
    Piaserico S; Piccioni A; Gutiérrez Garcìa-Rodrigo C; Sacco G; Pellegrini C; Fargnoli MC
    Photodiagnosis Photodyn Ther; 2021 Jun; 34():102325. PubMed ID: 33965603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pain during topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid and red light source: randomized controlled trial.
    Buinauskaite E; Zalinkevicius R; Buinauskiene J; Valiukeviciene S
    Photodermatol Photoimmunol Photomed; 2013 Aug; 29(4):173-81. PubMed ID: 23815349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial.
    Miola AC; Ferreira ER; Lima TRR; Schmitt JV; Abbade LPF; Miot HA
    Br J Dermatol; 2018 Nov; 179(5):1081-1087. PubMed ID: 29862491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies.
    Hauschild A; Stockfleth E; Popp G; Borrosch F; Brüning H; Dominicus R; Mensing H; Reinhold U; Reich K; Moor AC; Stocker M; Ortland C; Brunnert M; Szeimies RM
    Br J Dermatol; 2009 May; 160(5):1066-74. PubMed ID: 19222455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Pharmacokinetics and Safety of a 10% Aminolevulinic Acid Hydrochloride Nanoemulsion Gel (BF-200 ALA) in Photodynamic Therapy of Patients Extensively Affected With Actinic Keratosis: Results of 2 Maximal Usage Pharmacokinetic Trials.
    Novak B; DuBois J; Chahrour O; Papusha T; Hirt S; Philippi T; Zogel C; Osenberg K; Schmitz B; Lübbert H
    Clin Pharmacol Drug Dev; 2022 Apr; 11(4):535-550. PubMed ID: 34633154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.